Research location
Engel's
Russia
Advertisement
Research activity in Engel's
RussiaCureCurrent currently publishes aggregate city-level research activity for this location: 18 trials and 19 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Engel's
18 linked trials · page 1 of 1Registry of Arterial HypertensionNCT04160533 · 2018-06-01 · 2 site observations
RECRUITING
Vortioxetine to Prevent Return of Symptoms in Children With DepressionNCT05014919 · 2021-08-10 · 1 site observation
TERMINATED
A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant TherapyNCT04513912 · 2020-09-15 · 1 site observation
COMPLETED
Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From DepressionNCT04448431 · 2020-06-18 · 1 site observation
COMPLETED
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With SchizophreniaNCT04092686 · 2019-10-14 · 1 site observation
COMPLETED
Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of AgeNCT02871297 · 2016-08-17 · 1 site observation
TERMINATED
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD)NCT02709655 · 2016-05-18 · 1 site observation
COMPLETED
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)NCT02709746 · 2016-05-01 · 1 site observation
COMPLETED
F17464 in Acute Schizophrenia TrialNCT02151656 · 2014-06-01 · 1 site observation
COMPLETED
Epidemiological Study to Describe Non Small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Central Eastern Europe and Russia (Lung-EPICLIN)NCT01069835 · 2010-02-01 · 1 site observation
COMPLETED
Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast CancerNCT01091168 · 2009-07-01 · 1 site observation
COMPLETED
Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast CancerNCT00703326 · 2008-08-06 · 1 site observation
COMPLETED
A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)NCT00571675 · 2007-10-01 · 1 site observation
COMPLETED
Study of Picoplatin Efficacy After RelapseNCT00465491 · 2007-04-01 · 1 site observation
UNKNOWN
A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.NCT00448591 · 2006-09-01 · 1 site observation
COMPLETED
A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.NCT00451906 · 2006-08-01 · 1 site observation
COMPLETED
Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung CancerNCT00363415 · 2006-08-01 · 1 site observation
COMPLETED
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerNCT00097344 · 2004-12-01 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.